Rovertis Pharmaceuticals Private Limited
About Rovertis Pharmaceuticals Private Limited
Data last updated:
Rovertis Pharmaceuticals Private Limited is a private limited company based in Telangana, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 04 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044325. Its GSTIN is 36AACCR9866N1ZH (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹9.56 Lakh. It is led by directors including Krishnam Raju Vegesna and Swarupa Rani Chintala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061.
As per the financials filed for FY 2023, the company reported a revenue of ₹63.34 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Lakh (net margin 2.1%) and EBITDA of ₹1.79 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
CIN History of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2004PTC044325. The current CIN is U24239TG2004PTC044325, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044325 | Current |
| U24239AP2004PTC044325 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rovertis Pharmaceuticals Private Limited
The main business activity of Rovertis Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rovertis Pharmaceuticals Private Limited FY 2025 filings available
Rovertis Pharmaceuticals Private Limited reported revenue of ₹63.34 Lakh (down 10% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Rovertis Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 10% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rovertis Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rovertis Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rovertis Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnam Raju Vegesna | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Swarupa Rani Chintala Also directs: Swaroop Cosmetics Private Limited | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Padma Rajaboina | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Rajitha Rajaboina | Director | 20 Dec 2010 | 15 Years 10 Months | Current |
| Swarna Latha Pagadala | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Sreenivasa Rao Devarakonda | Director | 20 Dec 2010 | 15 Years 10 Months | Current |
Peer Comparison of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Welbeck Pharmaceuticals Private Limited | ₹63.48 Lakh (FY 2025) | •••• | •••• | -20.0% | •••• | New Delhi, Delhi, India |
| Aketkure Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Purnia, Bihar, India |
| LMGG Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2025) | •••• | •••• | 147.0% | •••• | Jaipur, Rajasthan, India |
| Driven Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2024) | •••• | •••• | 48.0% | •••• | Lucknow, Uttar Pradesh, India |
| Kiaora Pharmaceuticals Private Limited | ₹63.35 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Jalandhar, Punjab, India |
| Rovertis Pharmaceuticals Private Limited this company | ₹63.34 Lakh (FY 2023) | •••• | •••• | -10.0% | •••• | Telangana, India |
| Sarvam Jothy Pharmaceuticals Private Limited | ₹63.26 Lakh (FY 2024) | •••• | •••• | 968.0% | •••• | Chennai, Tamil Nadu, India |
| Tanik Pharmaceuticals Private Limited | ₹63.19 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Chennai, Tamil Nadu, India |
| Genderma Pharmaceuticals Private Limited | ₹63.13 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Uttar Pradesh, India |
| Susruta Pharmaceuticals Private Limited | ₹63.09 Lakh (FY 2022) | •••• | •••• | -26.0% | •••• | Kolkata, West Bengal, India |
| Nicd Pharmaceuticals Private Limited | ₹63.03 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Tenali, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Rovertis Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals Private Limited is audited by G.SAILEKH RAJ & ASSOCIATES for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G.SAILEKH RAJ & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rovertis Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rovertis Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Rovertis Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals Private Limited has 8 board changes on record since 2004: 6 appointments and 2 cessations. The latest: Rajitha Rajaboina was appointed as Director on 20 Dec 2010.
Credit Ratings, Litigation & Regulatory Alerts for Rovertis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rovertis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rovertis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCR9866N1ZH | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rovertis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals is an active private limited company based in Telangana, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 04 October 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044325.
Rovertis Pharmaceuticals reported revenue of ₹63.34 Lakh for FY 2023 (down 10% YoY).
Rovertis Pharmaceuticals has 6 current directors:
- Krishnam Raju Vegesna - Director
- Swarupa Rani Chintala - Director
- Padma Rajaboina - Director
- Rajitha Rajaboina - Director
- Swarna Latha Pagadala - Director
- Sreenivasa Rao Devarakonda - Director
Rovertis Pharmaceuticals reported a net profit of ₹1.33 Lakh (net margin 2.1%) and EBITDA of ₹1.79 Lakh (EBITDA margin 2.8%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rovertis Pharmaceuticals is -11% over three years and -4% over five years. In the latest year (FY 2023) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rovertis Pharmaceuticals is 36AACCR9866N1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Rovertis Pharmaceuticals is U24239TG2004PTC044325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rovertis Pharmaceuticals was incorporated on 04 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Rovertis Pharmaceuticals by revenue are Welbeck Pharmaceuticals Private Limited, Aketkure Pharmaceuticals Private Limited, LMGG Pharmaceuticals Private Limited, Driven Pharmaceuticals Private Limited, Kiaora Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rajitha Rajaboina was appointed as Director on 20 Dec 2010. Sreenivasa Rao Devarakonda was appointed as Director on 20 Dec 2010. Srinivas Rajaboina ceased to be Director on 20 Dec 2010. Rovertis Pharmaceuticals has 8 board changes on record in total.
The registered office of Rovertis Pharmaceuticals is at 12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061.